|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 6 |
| 2 | Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance显示文摘 | Ritzel R Schulte M Nauck M A | 2001 | Diabetes2001，50，： | 2 |
| 3 | Efficacy and safety comparison of liraglutide,glimepiride,and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | | Diabetes Care0，，： | 2 |
| 4 | Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemie control and lowers body weight in subjects with type 2 diabetes显示文摘 | Nauck MA Hompesch M Filipczak R | 2006 | Exp Clin Endocrinol Diabetes2006，114，8： | 1 |
| 5 | GLP-1R agonists (incretin mimetics ) andDPP-4 inhibitors ( incretin enhancers ) for the treatment of tupe 2diabetds显示文摘 | Drucder D J Nauck M A | 2006 | Lancet2006，368，9： | 1 |
| 6 | Towards the automation of intelligent data analysis显示文摘 | Spott M Nauck D | 2006 | Applied Soft Computing2006，6，8： | 1 |
| 7 | Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes显示文摘 | Maggs D MacDonald I Nauck M A | 2008 | Diabetes Obes Metab2008，10，1： | 1 |
| 8 | Glucagon-like peptide-1 in type 2 diabetes:theβcell and beyond显示文摘 | Nauck M | 2008 | Diabetes Obes Metab2008，10，3： | 1 |
| 9 | Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome 显示文摘 | Krueger M Heinzmann A Nauck M | 2007 | Intensive Care Med2007，33，2： | 1 |
| 10 | Proliferation of human non- small-cell lung cancer cell lines : role of interleukin-6 显示文摘 | BIHL M TAMM M NAUCK M | 1998 | Am J Respir Cell Mol Biol1998，19，4： | 1 |
| 11 | Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study 显示文摘 | Seck T Nauck M Sheng D | 2010 | Int J Clin Pract2010，64，5： | 1 |
| 12 | Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD(liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，1： | 1 |
| 13 | Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein (a) by agarose gel electrophoresis and enzymatic cholesterol staining 显示文摘 | Nauck M Winkler M Marz W | 1995 | Clin Chem1995，41，： | 1 |
| 14 | Exenatide once weekly versus lira- glutide once daily in patients with type 2 diabetes (DURATION-6) : a randomised, open-label study显示文摘 | Buse J B Nauck M Forst T | 2013 | Lancet2013，381，9861： | 1 |
| 15 | Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with mefformin in type 2 diabetes: 2-year results from the LEAD-2 study显示文摘 | Nauck M Frid A Hermansen K | 2013 | Diabetes Obes Metab2013，150，： | 1 |
| 16 | Corticosteroids inhibit the expression of the vascular endothelial grow th factor gene in human vascular smooth mus-cle cells显示文摘 | Nauck M Karakiulakis G Perruchoud AP Papakonstantinou E Roth M | 1998 | Eur J Pharmacol1998，341，23： | 1 |
| 17 | Efficacy and safety comparison of liraglutide,glimepiride, and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (Liraglutide Effect and Action in Diabetes )-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | J Diabetes Care2009，32，1： | 1 |
| 18 | Efficacy and safety comparison ofliraglutide, glimepiride, and placebo, all in combination with metformin, intype 2 diabetes: the LEAD -2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，： | 1 |
| 19 | Efficacyand safety of dulaglutide versus sitagliptin after 52 weeksin type 2 diabetes in a randomized controlled trial(AWARD-5)显示文摘 | Nauck M Weinstock RS Umpierrez GE | 2014 | Diabetes Care2014，37，： | 1 |
| 20 | Association between serum IGF-I and IGFBP-3 and lung function显示文摘 | Glaser S Friedrich N Ewert R Schaper C Nauck M DOIT M | 2009 | J Clin Endocrinol Metab2009，94，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员